First Time Loading...
M

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993

Watchlist Manager
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Watchlist
Price: 27.84 CNY 2.5% Market Closed
Updated: May 4, 2024

Mayinglong Pharmaceutical Group Co Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayinglong Pharmaceutical Group Co Ltd
Operating Expenses Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
M
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Operating Expenses
-¥995.9m
CAGR 3-Years
-13%
CAGR 5-Years
-9%
CAGR 10-Years
-8%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Expenses
-¥5.4B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Expenses
-¥1.2B
CAGR 3-Years
-1%
CAGR 5-Years
-9%
CAGR 10-Years
-18%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Expenses
-¥15B
CAGR 3-Years
2%
CAGR 5-Years
-10%
CAGR 10-Years
-16%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Expenses
-¥6.7B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Operating Expenses
-¥346.3m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
N/A

See Also

What is Mayinglong Pharmaceutical Group Co Ltd's Operating Expenses?
Operating Expenses
-995.9m CNY

Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Operating Expenses amounts to -995.9m CNY.

What is Mayinglong Pharmaceutical Group Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-8%

Over the last year, the Operating Expenses growth was -13%. The average annual Operating Expenses growth rates for Mayinglong Pharmaceutical Group Co Ltd have been -13% over the past three years , -9% over the past five years , and -8% over the past ten years .